about
T-cell lymphomas, a challenging disease: types, treatments, and future.T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia.Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia.Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapyRisk stratification of adult T-cell leukemia/lymphoma using immunophenotypingAdult T-cell leukemia/lymphoma treatment in Bahia, Brazil.Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells.Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study.The Exceptional Oncogenicity of HTLV-1Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression.Safety and efficacy of mogamulizumab in patients with adult T-cell leukemia-lymphoma in Japan: interim results of postmarketing all-case surveillance.Interactions between inflammatory gene polymorphisms and HTLV-I infection for total death, incidence of cancer, and atherosclerosis-related diseases among the Japanese population.HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice.Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma.Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality.HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment.Viral Oncology: Molecular Biology and Pathogenesis.Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma.Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma.Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma.Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia.Highlights from the HTLV-1 symposium at the 2017 Australasian HIV and AIDS Conference held jointly with the 2017 Australasian Sexual Health Conference, November 2017, Canberra, Australia.A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis.The small molecule STF-62247 induces apoptotic and autophagic cell death in leukemic cells.Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphomaNovel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines
P2860
Q30244553-8E8AED00-F69F-415E-9F65-FAFFF4919E4CQ36205736-2D98BF24-69DD-4BDA-91D5-0B464FB51CCEQ36583644-A70DA31B-956E-4558-B3DA-8AC9A2D277B3Q36920449-D567CF9C-F848-4756-92C6-26B5627FE72CQ37588395-0C0F4A61-E0AA-4A36-927C-3F94377F5D9EQ37609458-4B13CBC6-00FE-4E28-811C-AFB9452BFA62Q37683306-E177C049-97E8-4B1C-B004-3E74DA31EA04Q37731757-E4EF1E11-7EE1-43F7-8B94-E12134FAB5B4Q37735639-BA32B335-A12D-4BD1-8EAA-F37F863223AFQ38952071-0E2DA193-EFCF-4885-A4BA-BEB9DA57F19AQ39031943-80E1A323-EAA0-4DD2-99B8-A51A290FE6FFQ39504805-1F7B225E-AE92-4D7C-B66F-9BACD259D164Q40053212-ACBAFDDC-A1B3-4F50-92D1-0D6D12512F43Q40166488-14732E28-FA3C-4A1C-8672-4765D896142CQ40174914-EFD1B23D-B28E-4855-8C58-44C5BE278164Q42378329-AF3DC3FB-263C-474D-A9E0-41AD26A63A88Q42921947-CF21DB76-B329-4ED0-B02D-20F8A2D95CB9Q47170880-1194F2D1-656C-4397-81DE-8A08EA69485FQ47562043-6E0FED2A-B161-4A8A-BC69-87D5EDEE3C91Q47571734-BB67FB39-7192-43A4-8751-FE7109EA474EQ47594125-C61FD4D9-F650-4DC0-B400-B409BDABFC23Q47595798-AB59C1D0-4723-4544-BA91-43673596EB8AQ47697048-53B165F0-CAE7-4056-97AE-1B8A5AFB3DF7Q48190929-C1F07DE5-625F-4777-9DE4-8C8DED6AF1BCQ50000058-CD1A7652-4ABF-410B-A3A0-A8E1826BC9FDQ50145911-C10A37E1-CA2C-440E-8B49-A986123A6E65Q50251667-F755FFCD-E104-4DEB-875A-CE5D4B28F7C2Q55222718-9DC088A4-06A7-42A4-AE01-15A59F5461EFQ55289233-283A4F6D-D1D4-4CFE-AC01-ACFAF021C3E3Q55428622-32BA8B28-A67D-40A5-9349-15907831A217Q56526175-F6738E50-A3C3-450A-A931-93FA211F60CBQ58798810-3EB7DDF1-A2D3-4939-970B-A76E91E23E49
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Treatment and survival among 1594 patients with ATL.
@en
type
label
Treatment and survival among 1594 patients with ATL.
@en
prefLabel
Treatment and survival among 1594 patients with ATL.
@en
P2093
P1433
P1476
Treatment and survival among 1594 patients with ATL.
@en
P2093
ATL-Prognostic Index Project
Atae Utsunomiya
Eisaburo Sueoka
Hiroo Katsuya
Hitoshi Matsuoka
Hitoshi Suzushima
Junji Suzumiya
Kazuo Tamura
Kenji Ishitsuka
Kiyoshi Yamashita
P304
P356
10.1182/BLOOD-2015-03-632489
P407
P577
2015-09-11T00:00:00Z